NP NEUROVIVE PHARMACEUTICAL

[ Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; food supplements, namely, antioxidant pills; food supplements, namely, antioxidants; antitumor drugs in the nature of tumor suppressing agents; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation being implants comprising living tissue; bouillons for bacteriological cultures; cachets being capsules sold empty for pharmaceutical preparations; capsules sold empty for pharmaceutical preparations; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; chemical preparations for pharmaceutical purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; chemicopharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; cytostatic drugs for medical purposes; decoctions for pharmaceutical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary use, namely, food for human and animal babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical use, namely, food for babies; digestive enzymes being dietary supplements; disinfectants; drugs for medical purposes in the nature of medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations, namely, elixirs for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; ] fungicides, herbicides; [ in vitro diagnostic preparations for medical use; skin lotions for medical purposes; skin lotions for pharmaceutical purposes; material for stopping teeth; material for stopping teeth, dental wax; media for bacteriological cultures; medical and veterinary preparations and products for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions for treating metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage, and neurological operations; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, brain damage, brain operations, and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditions, namely, for brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents for organ transplants; medicines and pharmaceutical preparations for neurological conditions within the area of neurological intensive care; medicines for human purposes in the nature of medicinal preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; mixed biological preparations for medical purposes, namely, for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; nutritional supplements; nutritional supplements for livestock feed; medicated ointments for medical purposes, namely, for treating dermatological conditions; pharmaceutical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs in the nature of pharmaceutical preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and ] other preparations for destroying vermin; fungicides and herbicides [ ; pharmaceutical preparations and substances for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for medical purposes and veterinary purposes, namely, for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria in the nature of antibacterial pharmaceuticals; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of viral diseases in the nature of antivirals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for neurological conditions within the area of neurological intensive care; pharmaceutical preparations for the prevention of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; pharmaceutical preparations for the treatment of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; medical and veterinary preparations for metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; medical plasters; medical dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; mineral salts for medical purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills being medical preparations for slimming purposes; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamide preparations; tinctures being medicinal drinks for medical purposes; tinctures being medicinal drinks for veterinary purposes; tonics being medicinal drinks; tonics being medicinal drinks for medical use; tonics being medicinal drinks for veterinary use; vaccines; vaccines for human use; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions including preventive treatment; the aforementioned rare diseases consisting of Alpers Disease, ALS (Amyotrophic Lateral Sclerosis), Autism, Barth syndrome, Complex I Deficiency (NADH dehydrogenase deficiency), Complex II Deficiency (NADH-CoQ reductase deficiency), Complex III Deficiency (Ubiquinone-cytochrome c oxidoreductase deficiency), Complex IV Deficiency/COX Deficiency, Complex V Deficiency (ATP synthase deficiency), CPEO (Chronic Progressive External Ophthalmoplegia Syndrome), Friedreich's ataxia (FRDA or FA), KSS (Kearns-Sayre Syndrome), Lactic Acidosis, Leigh Disease or Syndrome (Subacute Necrotizing Encephalomyelopathy), LHON (Leber's hereditary optic neuropathy), MELAS (Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike Episodes), MERRF (Myoclonic Epilepsy and Ragged-Red Fiber Disease), MIDD (Maternally Inherited Diabetes and Deafness), Mitochondrial Myopathy, MNGIE (Myoneurogastointestinal Disorder ) and Encephalopathy, NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa), Neurodegenerative disorders associated with Parkinson's, Alzheimer's or Huntington's disease, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, POLG Mutations ]

Chromatography apparatus for laboratory use; DNA chips; electrodes for laboratory research

[ Blood testing apparatus; electrodes for medical use; probes for medical purposes; probes for veterinary purposes; electrodes for veterinary use, namely, medical electrodes ]

[ Analysis of human tissues for medical research; bacteriological analysis and consultation relating thereto; biochemical research; biological analysis; scientific biological laboratory services; biological research and analysis; biological research, medical research and clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; biological sample analysis for scientific and medical research purposes; biological samples, blood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical research purposes; chemical analysis and research; chemical research and analysis services; chemistry consultancy services; clinical research in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; clinical research and trials for others in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; scientific research, namely, conducting clinical trials for others; conducting clinical trials being scientific research for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; ] consultancy in the field of cosmetics, namely, consultancy in connection with the quality inspection, research and development of cosmetic products and medicated cosmetic products [ ; consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceutical, pharmacogenetics, medical chemistry, and veterinary research; consultancy services in the field of biological research; consultancy services in the field of biotechnology; consulting on pharmacogenetics in the nature of pharmaceutical consultation; cosmetics research; cosmetics research and analysis services; cosmetics research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments for medical use; design and development of medical diagnostic apparatus and instruments; development, testing and consultancy services in the fields of biotechnology research, pharmaceutical research, medical research, veterinary medicine research, chemistry research, biology research, and pharmacogenetics research; DNA analysis for scientific and medical research purposes; drug and pharmaceutical discovery, testing and development services; drug discovery services; industrial analysis and research services in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; laboratory research services relating to pharmaceuticals; medical and veterinary product research and development and consultancy related thereto; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicines, drug discovery, drug development and drug screening, and consultancy related thereto; research and development in the field of biotechnology; biochemical research and development of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; scientific research and development services; research and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology products, pharmaceutical products, sanitary products, medical products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, and testing services, and consultancy related thereto, in the fields of biotechnology, pharmaceuticals, sanitary products, chemistry, biology and pharmacogenetics; research, development, testing and consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research, development, testing, scientific consultancy services in the fields of biotechnology products, pharmaceutical products, medical products, sanitary products, veterinary products, chemistry products, biology products, and pharmacogenetics products; research in the field of environmental protection; research, testing and development of sanitary, pharmaceutical, medical, medicinal chemical, veterinary preparations; research, testing and development of biotechnical, biological preparations; research, testing and development in the field of diagnostic preparations; research, testing and development of diagnostic preparations for medical purpose; scientific analysis in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction; scientific and technological services, namely, scientific research, analysis and testing in the fields of metabolic, neurological, cardiovascular and musculoskeletal diseases, cancer, diabetes, mitochondrial diseases, and rare diseases involving mitochondrial and/or metabolic dysfunction, and research and design relating thereto; scientific laboratory services; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; blood toxicity analysis; toxicity testing in the nature of drug screening for research purposes; veterinary laboratory services; the aforementioned rare diseases consisting of Alpers Disease, ALS (Amyotrophic Lateral Sclerosis), Autism, Barth syndrome, Complex I Deficiency (NADH dehydrogenase deficiency), Complex II Deficiency (NADH-CoQ reductase deficiency), Complex III Deficiency (Ubiquinone-cytochrome c oxidoreductase deficiency), Complex IV Deficiency/COX Deficiency, Complex V Deficiency (ATP synthase deficiency), CPEO (Chronic Progressive External Ophthalmoplegia Syndrome), Friedreich's ataxia (FRDA or FA), KSS (Kearns-Sayre Syndrome), Lactic Acidosis, Leigh Disease or Syndrome (Subacute Necrotizing Encephalomyelopathy), LHON (Leber's hereditary optic neuropathy), MELAS (Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike Episodes), MERRF (Myoclonic Epilepsy and Ragged-Red Fiber Disease), MIDD (Maternally Inherited Diabetes and Deafness), Mitochondrial Myopathy, MNGIE (Myoneurogastointestinal Disorder ) and Encephalopathy, NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa), Neurodegenerative disorders associated with Parkinson's, Alzheimer's or Huntington's disease, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, POLG Mutations ]

[ -Analysis of human serum for medical treatment; analysis of human tissues for medical treatment; ] consultancy in the field of cosmetics, namely, consultancy in connection with the selection of cosmetic products and medicated cosmetic products; [ consultancy in the medical field, other than dentistry; drug screening for medical purposes; health care; health care services; ] hygienic and beauty care for human beings or animals; [ medical and surgical diagnostic testing services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services in the nature of performing diagnosis of diseases; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; ] providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus [ ; veterinary consultancy services; veterinary services ]